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Abstract 
BACKGROUND: Small for gestational age children (SGA) is born on term with BW and or BL of -2.0 standard 
deviation score (SDS). SGA children have an increased risk of being short, developing DM, and cardiovascular 
and cerebrovascular disease. Often defects of IGF1R are the cause of SGA. Most frequently affected part of the 
IGF1R gene is the exon 2.  
AIM: To investigate whether the exon 2 of the IGF1R gene is affected in the SGA children. 
PATIENTS AND METHODS: A cohort of 100 SGA children born in term was evaluated for alterations in IG1R 
gene. Their anthropometric parameters, IGF1 serum concentrations and IGF1 SDS values were analysed. The 
molecular analysis of IGF1R gene was performed by PCR restriction-site analysis and followed by direct 
sequencing of conspicuous fragments. 
RESULTS: Within our cohort, 64 SGA children were with short stature (height SDS -3.25 ± 0.90 SDS), and 36 
were with normal height for their age and sex, (H SDS was 0.20 ± 1.1 SDS). None of these children had 
microcephaly (occipitofrontal circumference -0.70 ± 1.01 SDS vs 0.06 ± 0.56 SDS in SGA children with normal 
height) or dysmorphic features. The IGF1 serum concentrations and IGF1 SDS values of all children were within 
normal range. Only one child had lower normal serum IGF1 concentration. No alterations in exon 2 of IGF1R 
gene were detected. 
CONCLUSIONS: The genetic analysis of the exon 2 of the IGF1R gene did not detect any gene defects in the 
analysed patients. The putative genetic defect in those children affects other parts of the IGF1R gene or another 
gene (s), or yet unidentified factors. 
 
 
 
 
 
 
 
 
 
Introduction 
 
SGA children comprise 3% of all births. Those 
are the children with birth weight (BW) and/or birth 
length (BL) less than 2.0 standard deviation score 
(SDS). Only 10% of children do not attain normal 
height until the age of four or five years. In fact, that 
10 % have a higher risk to remain short, as well as 
increased prone to diabetes mellitus, cerebrovascular 
and cardiovascular diseases in adulthood [1].  
The aetiology of SGA is heterogeneous. 
Genetic factors are a culprit in some of them. Defects 
in IGF1R gene are reported as a cause of SGA [2] [3] 
[4]. The most affected part of the IGF1R gene is its 
exon 2.  
Insulin-like growth factor 1 receptor (IGF1R) is 
a heterotetrameric (α2β2) transmembrane 
glycoprotein with intrinsic kinase moiety. It contains 2 
alfa and two beta subunits synthetized by one mRNA 
precursor (α2β2). IGF-1R and IR (insulin receptor) are 
parts of the same family together with IGF-2R and 
their ligands IGF-1 and IGF-2 and at least 6 IGF-
binding proteins, so-called protein kinase superfamily 
or tyrosine protein kinase family and insulin receptor 
subfamily [5] [6] [7] [8]. GF1R and IR receptors are 
found in skeletal muscles, heart, kidneys, fat tissue, 
liver, spleen, fibroblasts and placenta.  
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We investigated the exon 2 of the IGF-1R 
gene, as this gene part is the often affected by 
nucleotide alterations. 100 SGA children were 
analysed.  
 
 
Patients and Methods 
 
The cohort of 100 (M:F = 40:60) children born 
in term (≥ 37 GW), but small for gestational age is 
composed of two groups: a group of 64 (M:F = 31:33) 
SGA born children who did not achieve catch-up 
growth after the 2nd year and remained short and a 
group of 36 (M:F = 13:23) SGA born children (older 
than 4 years) with normal growth spurts for their age 
and sex.  
Anthropometric data and IGF-1 
concentrations were evaluated. IGF1-BP3 was not 
available. Clinical birth data include children's birth 
weight (BW) in kilograms, BW standard deviation 
score (SDS), birth length (BL) in centimetres, BL SDS 
and gestation week (GW). Also, the height SDS, 
weight SDS, occipitofrontal circumference SDS, body 
mass index (BMI), BMI z-score and target height (TH) 
SDS were also analysed.  
The serum concentrations of Insulin-like 
growth factor 1 (IGF1) were determined by 
chemiluminescence immune assay method on 
IMMULITE 2000 Siemens, Immunoassay System 
apparatus. 
The molecular analysis of IGF1R gene was 
performed on ("Biometra"-T3 Thermocycler PCR 
apparatus) in Laboratory for Molecular medicine in 
University Children's Hospital Skopje. Start DNA 
material was isolated from leukocytes with high 
concentrated 5 M NaCl solution. This genomic DNA 
material of particular exon 2 was amplified using the 
polymerase chain reaction (PCR) to perform the 
restriction-site analysis. We used following primers: 
5'TCGACATCCGCAACGACTATC3' as the forward 
primer and the 5'CGAAGATGACCAGGGCGTAG3' as 
reverse primer. PCR products were digested with Dde 
I (Sigma Aldrich), and the resulting fragments were 
characterized by 1% agarose gel horizontal 
electrophoresis and staining with ethidium bromide. 
PCR products of coding IGF1R exon 2 were screened 
by direct sequencing of conspicuous fragments in 
Molecular Laboratory of Faculty of Pharmacy.  
The Kolmogorov-Smirnov test (KS test) is 
used to check whether the values have a normal 
(Gaussian) distribution. A confidence interval (CI) is 
calculated for the mean of each of the quantities. For 
the comparison of 2 groups, Fisher's test is used to 
check the equivalence of variances. The result of this 
test is relevant for applying the test for equivalence of 
means. If the 2 samples have a size greater than 30, 
a z-test is used, otherwise a t-test. All tests are with a 
99% significance or α = 0.01. 
 
 
Results 
 
The mean birth weight (BW) and BW standard 
deviation score (BW SDS), birth length (BL) and BL 
SDS were: in 64 short children BW 2284.37 gr ± 433 
SDS and BW SDS -2.71 ± 1.05 SDS, BL 47.06 ± 2.09 
SDS and BL SDS -1.33 ± 1.03 SDS and in 36 children 
with normal height BW 2502.5 gr ± 317.8 SDS and 
BW SDS -2.15 ± SDS and BL 46.63 cm ± 2.12 SDS 
and BL SDS -1.61 ± 1.12 SDS (Table 1). 
Table 1: Birth parameters: Birth weight (BW), BW SDS, birth 
length (BL), BL SDS and Gestation Week (GW) in 2 groups of 
children: a group of 64 short SGA born children and group of 
36 SGA born children with normal height 
Groups 
 
 
 
Parameters 
Short SGA 
Children 
SGA children with 
Normal height 
Comparison 
Between 
Two groups 
Mean 
P-
value 
From 
Ks test 
Mean 
P-value 
From 
Ks test 
P-value 
BW Gr 2284.37±433 SDS 0.18 2502.5±317.8 SDS 0.97 0.0095 
BW SDS - -2.71±1.05 SDS 0.78 -2.15± 0.56SDS 0.48 0.0009 
BL Cm 47.06±2.09 SDS 0.56 46.63±2.12 SDS 0.87 0.33 
BL SDS - -1.33±1.03 SDS 0.34 -1.61±1.12 SDS 0.93 0.22 
GW W 39.17±0.94 SDS 0.46 39.34±0.90 SDS 0.61 0.37 
Patients 
M N=31 N=13 
 
F N=33 N=23 
 
Short children had measured height SDS (H 
SDS) (-3.25 ± 0.90 SDS), weight SDS (W SDS) (-2.72 
± 1.39 SDS), BMI z-score (0.88 ± 1.78 SDS) and 
occipitofrontal circumference SDS (OFC SDS) (-0.70 
± 1.01 SDS) at the time of entrance the study. Growth 
parameters of children with caught up growth were: H 
SDS (0.20 ± 1.1 SDS), W SDS (0.29 ± 1.53 SDS), 
BMI z-score (0.01 ± 1.68 SDS) and OFC SDS (0.06 ± 
0.56 SDS) (Table 2). 
Table 2: Auxology parameters: height SDS (H SDS), weight 
SDS (W SDS), BMI and BMI z-score, occipitofrontal 
circumference SDS (OFC SDS), Target Height SDS (TH SDS) in 
2 groups of children: a group of 64 short SGA born children 
and group of 36 SGA born children with normal height 
Groups 
 
 
Parameters 
Short SGA 
Children 
SGA children with 
Normal height 
Comparison 
Between 
Two groups 
Mean 
P-value 
From 
Ks test 
Mean 
P-
value 
From 
Ks test 
P-value 
H SDS - -3.25±0.90 SDS 0.19 0.20±1.1 SDS 0.62 0.024 
W SDS - -2.72±1.39 SDS 0.45 0.29±1.53 SDS 0.65 3.30e-16 
BMI Kg/m
2
 15.25±2.15 SDS 0.41 17.28±4.39 SDS 0.14 0.012 
BMI Z-
SCORE 
- -0.88±1.78 SDS 0.31 0.01±1.68 SDS 0.70 0.015 
OFC SDS - -0.70±1.01 SDS 0.91 0.06±0.56 SDS 0.95 3.82e-06 
TH SDS - -1.00±0.87 SDS 0.52 0.15±0.91 SDS 0.98 6.98e-9 
 
None of our SGA born children had 
dysmorphic features. 
Only in one boy with short stature (-2.63 SDS) 
had low normal IGF1 serum concentration (52.3 
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ng/ml, N = 50-286) and IGF1 SDS (-1.57 SDS) for his 
age and sex. The PCR restriction-site analysis in all 
SGA born children did not show any genetic alteration 
in exon 2 of IGF1R gene. The screened PCR products 
coding IGF1R exon 2 by direct sequencing of 
conspicuous fragments were uneventful. 
 
 
Discussion 
 
Several alterations (point mutations and 
deletions)
 
in the IGF1 and insulin-like growth factor 1 
receptor
 
(IGF-1R) genes have been demonstrated last 
decade. Alterations have been identified that affect 
IGF1R biosynthesis, signal reception and receptor 
kinase activity [9] [10] [11] [12] [13] [14] [15] [16] [17] 
[18] [19].  
Homozygous defects in the IGF1 gene have 
been found in patients with major developmental 
impairments and severe intrauterine and postnatal 
growth retardation. On the other hand, mutations in 
IGF1R gene that have been predominantly 
heterozygous are 3 found in patients with mild 
phenotype and clinically heterogeneous presentation 
[20].  
Since 2003y Abuzzahab et al., [10] described 
2 point mutations in exon 2 of IGF1R gene: the first 
was compound heterozygosity with the exchange of 
arginine by glutamine at amino acid 108 (p. R108Q) 
and exchange for lysine by asparagine in the amino 
acid 115 (p. K115N) in SGA born girl with delayed 
motor development, psychiatric problems and growth 
retardation. The authors also described another 
heterozygous mutation in the éxon 2 (p. R89X) in an 
IUGR born boy with microcephaly, short stature and 
delayed motor and speech development.  
Kawashima et al., [11] in 2005 described 
missense mutation in heterozygosity at 11 éxon the 
IGF1R (p. R739Q) in a SGA born patient with 
significant mental retardation and postnatal growth. In 
SGA born 35 y old patient with microcephaly and 
elevated IGF1 values, Walenkamp et al., [12] 2006y 
found a mutation in the éxon 16 (p. E1050K). Inagaki 
et al., [13] 2007y found heterozygous point mutation 
resulting in R481Q in a girl with short stature and 
elevated IGF1 values. Kruis et al., 2010y [14] in 7 
members of the same family with low BW, 
microcephaly and normal mental development, 
reported similar mutation which resulted in G1125A 
protein.  
Wallborn et al., [15] found a mutation of 
IGF1R gene p. V599E in SGA born patient with 
microcephaly, mental retardation and elevated IGF1 
levels. Fang et al., 2009 [16] reported novel 
heterozygous 19 nucleotides duplication within 18 
éxon of IGF1R gene and consequently to 
haploinsufficiency of IGF1R protein in 4 short statured 
family members with normal IGF1 levels. Mohn et al., 
2011 [17] described 4 SGA family members with short 
stature and impaired glucose metabolism with a novel 
mutation (p.Tyr387X).  
Labarta et al., 2013 [21] described novel 
heterozygous IGF1R missense mutation in exon 7 
(c.A1549T, p.Y487F) in 3 IUGR born females from the 
same family with short stature and microcephaly. 
Juanes et al., [22] 2015 identified three novel 
heterozygous missense mutations in 3 patients with 
microcephaly and growth retardation, de novo 
p.Arg1256Ser, de novo p.Asn359Tyr and 
p.Tyr865Cys.  
We investigated 100 SGA born children, 64 
children were with short stature -H SDS (-3.25 ± 0.90 
SDS) and 36 children with normal height -H SDS 
(0.20 ± 1.1 SDS). They were born with low BW SDS (-
2.71 ± 1.05 SDS) vs (-2.15 ± 0.56 SDS) and/or BL 
SDS (-1.33 ± 1.03 SDS) vs (-1.61 ± 1.12 SDS). No 
alterations in exon 2 of the IGF1R gene were found.  
The IGF1 serum concentration only in one 
patient of our cohort was in the lower normal range for 
his age and sex at the time of diagnosis. The defects 
of IGF1R usually result in elevated IGF1 serum 
concentrations [2] [12] [13] [15].  
In conclusion, within a cohort of 100 SGA 
born children without microcephaly or dysmorphic 
features we did not find alterations in the exon 2 of the 
IGF1R gene. Exon 2 of the IGF1R gene might not be 
a hotspot for alterations. Investigating most or the 
whole of the IGF1R gene together with other genes 
implicated in SGA might yield an answer on the SGA 
cause of a particular child.  
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